Menopause is a natural stage of reproductive aging that marks the end of menstrual periods and the ability to become pregnant naturally. It occurs when ovarian function declines and the ovaries stop releasing eggs regularly, leading to a sustained reduction in reproductive hormone production.
Natural menopause is generally confirmed after 12 consecutive months without a menstrual period, provided there is no other medical or physiological explanation for the absence of menstruation.
In the United States, natural menopause typically occurs between ages 45 and 55, with an average age of approximately 51.
Although menopause is a normal biological transition rather than a disease, the hormonal changes associated with it can affect sleep, body temperature regulation, sexual health, mood, bone health, and overall well-being.
Some women experience few symptoms, while others develop hot flashes, night sweats, vaginal dryness, sleep disturbances, fatigue, or other changes that interfere with daily activities and quality of life.
Understanding the causes, symptoms, diagnostic process, and available treatment options can help women navigate menopause with accurate information and realistic expectations.
Types of Menopause
Menopause may occur naturally as part of aging or result from medical treatments that affect ovarian function.
Understanding the circumstances surrounding menopause can help guide evaluation and treatment.
Natural Menopause
Natural menopause occurs when ovarian follicle activity declines with age.
As the ovaries produce less estrogen and progesterone, menstrual cycles eventually stop.
The timing varies, but most women experience natural menopause between ages 45 and 55.
Early Menopause
Early menopause refers to menopause occurring between ages 40 and 44.
It may occur naturally or be associated with certain medical treatments or health conditions.
Because earlier estrogen loss can affect bone and cardiovascular health, women experiencing early menopause may need additional evaluation and discussion of hormone therapy when appropriate.
Premature Menopause and Primary Ovarian Insufficiency
Menopause-like changes occurring before age 40 require evaluation for primary ovarian insufficiency (POI).
POI involves reduced ovarian function before age 40, but it is not identical to permanent natural menopause. Some individuals with POI experience intermittent ovarian activity and occasional ovulation.
Possible causes include genetic conditions, autoimmune disorders, and certain medical treatments, although many cases have no identifiable cause.
Diagnosis and management differ from typical age-related menopause.
Surgical Menopause
Surgical menopause occurs when both ovaries are removed before natural menopause.
Because ovarian hormone production falls abruptly, symptoms may begin suddenly and can be more intense than those associated with gradual reproductive aging.
Removal of the uterus alone does not necessarily cause menopause if the ovaries remain functional, although it eliminates menstrual bleeding and may make the timing of menopause harder to recognize.
Treatment-Induced Menopause
Certain cancer treatments, including some chemotherapy regimens and pelvic radiation, can damage ovarian function.
Depending on the treatment and individual circumstances, ovarian suppression may be temporary or permanent.
Medications used to suppress ovarian hormones can also produce menopause-like symptoms without necessarily causing permanent menopause.
Causes of Menopause
Menopause results primarily from changes in ovarian function and reproductive hormone production.
The underlying mechanism differs depending on whether menopause occurs naturally or follows medical treatment.
Age-Related Decline in Ovarian Follicles
Women are born with a finite number of ovarian follicles.
Throughout reproductive life, the number of remaining follicles gradually decreases.
As ovarian follicles become fewer and less responsive to hormonal signals, ovulation becomes less predictable and eventually stops.
This process leads to the permanent cessation of menstrual periods.
Declining Estrogen Production
Estrogen plays an important role in menstrual regulation, bone maintenance, vaginal tissue health, and body temperature control.
During the years leading up to menopause, estrogen levels may fluctuate considerably.
After menopause, ovarian estrogen production remains substantially lower than during the reproductive years.
Lower estrogen levels contribute to several menopause-related symptoms, including hot flashes, vaginal dryness, and accelerated bone loss.
Changes in Progesterone Production
Progesterone is produced mainly after ovulation.
As ovulation becomes irregular during the menopausal transition, progesterone production also becomes less predictable.
Following menopause, ovulation ceases and ovarian progesterone production falls markedly.
Changes in Brain-Ovary Hormonal Signaling
The brain and ovaries communicate through hormones, including follicle-stimulating hormone (FSH) and luteinizing hormone (LH).
As ovarian hormone production declines, FSH levels generally rise.
However, hormone levels can fluctuate during the transition, which limits the usefulness of a single blood test for diagnosing menopause in many women.
Factors That May Influence Menopause Timing
Several factors are associated with earlier or later menopause, including:
- Genetics: Family history can influence the age at which natural menopause occurs.
- Smoking: Smoking is associated with earlier menopause.
- Cancer treatments: Chemotherapy and pelvic radiation may affect ovarian function.
- Ovarian surgery: Removal of both ovaries causes surgical menopause.
- Certain medical conditions: Genetic and autoimmune disorders may contribute to ovarian insufficiency.
These factors influence risk or timing but do not determine precisely when menopause will occur for every individual.
Symptoms of Menopause
Menopause symptoms vary in severity and duration.
Some symptoms begin during perimenopause, the transition leading up to menopause, and continue afterward.
Others become more noticeable as estrogen levels remain low.
Hot Flashes
Hot flashes are among the most common menopause symptoms.
They involve a sudden sensation of heat, often affecting the face, neck, or chest.
A hot flash may include:
- Sweating
- Facial flushing
- A rapid heartbeat
- Chills after the episode
Hot flashes can last from seconds to several minutes and may occur repeatedly throughout the day.
Their frequency and severity vary considerably.
Night Sweats
Night sweats are hot flashes that occur during sleep.
They may cause significant sweating, awakenings, and disrupted rest.
Repeated nighttime symptoms can contribute to fatigue, irritability, and difficulty concentrating.
Sleep Disturbances
Menopause can be associated with difficulty falling asleep, staying asleep, or feeling rested.
Night sweats are a common contributor, but insomnia may occur independently.
Other factors, including stress, mood disorders, medication effects, and sleep apnea, can also affect sleep quality.
Fatigue is also commonly experienced during menopause, which may or may not be related to sleep issues.
Vaginal Dryness and Irritation
Lower estrogen levels can cause changes in vaginal and vulvar tissues.
Symptoms may include:
- Dryness
- Burning
- Irritation
- Reduced lubrication
- Discomfort during sexual activity
These symptoms are part of a condition known as genitourinary syndrome of menopause (GSM).
Unlike hot flashes, which may improve over time, GSM symptoms often persist or worsen without appropriate treatment.
Painful Intercourse
Changes in vaginal tissue elasticity and lubrication may contribute to discomfort or pain during intercourse.
Pain can also have other causes, including pelvic floor muscle dysfunction, skin conditions, or infections.
Evaluation can help identify which treatments are appropriate.
Changes in Sexual Desire
Some women notice reduced sexual desire during or after menopause.
Sexual desire is influenced by multiple factors, including hormonal changes, sleep, stress, relationship circumstances, mood, medications, and physical discomfort.
Menopause does not affect sexual function in the same way for everyone.
Mood Changes
Some women experience irritability, anxiety, or depressive symptoms during the menopausal transition.
Hormonal fluctuations, sleep disruption, life circumstances, and previous mental health history may contribute.
Although mood symptoms may overlap with menopause, persistent depression or anxiety requires appropriate evaluation and treatment.
Difficulty Concentrating and Memory Changes
Some women report forgetfulness or difficulty concentrating during midlife.
These symptoms are sometimes described as brain fog.
Sleep problems, stress, mood symptoms, and hormonal changes may contribute.
Persistent or worsening cognitive symptoms should not automatically be attributed to menopause.
Urinary Symptoms
Lower estrogen levels can affect urinary and genital tissues.
Symptoms may include:
- Urinary urgency
- Burning or discomfort
- Recurrent urinary tract infections
- Urinary frequency
Not every urinary symptom is caused by menopause, so other conditions may need to be considered.
Joint and Muscle Discomfort
Joint aches and musculoskeletal discomfort may become more noticeable around menopause.
Hormonal changes, aging, physical activity, and other medical conditions can contribute.
Persistent or significant pain warrants evaluation for alternative causes.
Changes in Body Composition
During midlife, some women notice an increase in abdominal fat or changes in muscle mass.
Menopause-related hormonal changes may influence fat distribution, while aging, sleep, nutrition, medical conditions (i.e., thyroid disorders), and physical activity also affect body composition.
Menopause does not inevitably cause substantial weight gain.
Long-Term Bone Health Changes
Estrogen helps maintain bone density.
After menopause, declining estrogen levels accelerate bone loss, increasing the risk of osteoporosis and fractures.
Bone loss often produces no symptoms until a fracture occurs, making appropriate risk assessment and screening important.
How Is Menopause Diagnosed?
Menopause is usually diagnosed using menstrual history, age, symptoms, and clinical context.
For many women, routine laboratory testing is unnecessary; however, hormone levels can be a useful assessment tool in some clinical scenarios.
Menstrual History
Natural menopause is generally identified after 12 consecutive months without a period when no other explanation is present.
This definition is most useful for women who are not using medications or contraceptives that alter menstrual bleeding.
Symptom Review
A healthcare professional may ask about:
- Changes in menstrual patterns
- Hot flashes and night sweats
- Sleep disturbances
- Vaginal or urinary symptoms
- Sexual health concerns
- Mood changes
- Medical history and medications
Symptoms often begin before the final menstrual period and continue afterward, lasting on average 4 years and up to a decade and beyond for some women.
Hormone Blood Tests
FSH and estradiol levels change during the menopausal transition.
However, these hormones fluctuate, particularly during perimenopause.
For otherwise healthy women aged 45 or older with typical symptoms and menstrual changes, menopause is usually diagnosed clinically without routine hormone testing.
Blood testing may be considered when menopause occurs unusually early or the clinical picture is uncertain.
Diagnosing Menopause After Hysterectomy
Women who have undergone hysterectomy may not have menstrual periods to indicate the transition.
If the ovaries remain, menopause can still occur naturally.
In these circumstances, age, symptoms, medical history, and selected testing may help guide assessment.
Evaluating Early or Premature Menopause
Menstrual cessation before age 45 may warrant additional assessment, particularly when symptoms begin before age 40.
Evaluation may include hormone testing and investigation for primary ovarian insufficiency or other causes.
Identifying earlier ovarian hormone loss is important because it can influence bone, cardiovascular, and reproductive health planning.
Ruling Out Other Causes
Not all symptoms occurring during midlife are caused by menopause.
Depending on the presentation, evaluation may consider:
- Pregnancy
- Thyroid disorders
- Anemia
- Medication effects
- Sleep disorders
- Depression or anxiety
- Other causes of abnormal uterine bleeding
Any vaginal bleeding after menopause has been established should be medically evaluated, even if it is light or occurs only once.
Post-menopausal bleeding is caused by endometrial cancer in approximately 5-10% of cases, so prompt evaluation is critical.
Treatment Options for Menopause
Menopause itself does not require treatment.
However, symptoms and related health concerns can often be managed effectively.
Treatment decisions should consider symptom severity, age, time since menopause, medical history, contraindications, and personal preferences.
Menopausal Hormone Therapy
Systemic menopausal hormone therapy is first-line treatment and is the most effective established treatment for bothersome hot flashes and night sweats.
Hormone therapy generally includes estrogen, with bioidentical progesterone or a synthetic progestogen added for women who have a uterus to protect the uterine lining. Bioidentical progesterone can be used in women without a uterus who desire to use it for additional symptom relief, when appropriate.
Estrogen therapy has also been shown to prevent bone loss while treatment continues.
Common forms include:
- Oral tablets
- Transdermal patches
- Gels
- Sprays
Injections and vaginal rings are also available, although less commonly used.
Women who have undergone hysterectomy may be able to use estrogen without bioidentical progesterone or a progestin, depending on their medical circumstances.
For many healthy women younger than 60 or within 10 years of menopause onset, the benefit-risk balance of hormone therapy is generally favorable when treating bothersome symptoms and when no contraindications are present. Starting hormone therapy outside of this recommended time window is still an option, depending on individualized risk-benefit assessment.
However, hormone therapy is not appropriate for everyone.
Potential risks depend on the formulation, dose, route, duration, and individual medical history.
Certain conditions, including a history of some cancers, blood clots, stroke, unexplained vaginal bleeding, or significant liver disease, may make systemic hormone therapy inappropriate.
FDA-Approved Bioidentical Hormone Therapy
Bioidentical hormones have the same molecular structure as hormones produced by the human body.
Certain FDA-approved estradiol and micronized progesterone medications are bioidentical.
These products have undergone regulatory evaluation for their approved uses.
Custom-compounded bioidentical hormone products are different. Compounded formulations generally lack the same regulatory review for safety, effectiveness, consistency, and quality.
When appropriate FDA-approved products are available, custom-compounded hormones are generally not recommended as routine alternatives. Compounded hormones can be a good option in certain situations, but the risks of the unregulated nature of custom-compounded medications should be considered.
Nonhormonal Prescription Treatments
Some women prefer nonhormonal treatment or have medical conditions that make systemic hormone therapy not an option.
Evidence-supported prescription options for hot flashes, night sweats, and mood symptoms include certain antidepressants, such as selected selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs), and other medications.
Veozah and Lynkuet are nonhormonal neurokinin 3 receptor antagonists and are both approved for the treatment of moderate to severe vasomotor symptoms associated with menopause. They require regular liver function lab testing before starting and during treatment, as they carry a warning for rare but serious liver injury.
Medication choice depends on individual risks, potential interactions, symptom severity, and current prescribing guidance.
Treatment for Vaginal Dryness and Genitourinary Symptoms
Genitourinary syndrome of menopause may respond to local treatments.
Options include:
- Vaginal moisturizers
- Lubricants
- Low-dose vaginal estrogen
- Vaginal dehydroepiandrosterone (DHEA)
- Other prescription therapies when appropriate
Low-dose vaginal estrogen primarily treats local tissues and generally results in much lower systemic hormone exposure than systemic hormone therapy.
Patients with a history of estrogen-sensitive cancer may require additional individualized discussion before using hormonal treatments.
Managing Painful Intercourse
Treatment depends on the underlying cause.
When discomfort is related to vaginal dryness or tissue changes, moisturizers, lubricants, or local hormonal treatment may help.
Pelvic floor physical therapy may be appropriate when muscle tension or pelvic floor dysfunction contributes to pain.
Persistent pain should be evaluated rather than assumed to result solely from estrogen deficiency.
Lifestyle and Symptom Management
Lifestyle practices can support overall health during and after menopause.
These may include:
- Regular physical activity
- Resistance and weight-bearing exercise
- Balanced nutrition
- Adequate calcium and vitamin D intake
- Consistent sleep habits
- Smoking cessation
- Limiting alcohol
- Managing cardiovascular risk factors
These approaches can improve general well-being, although they may not fully relieve moderate or severe hot flashes.
Cognitive Behavioral Therapy and Clinical Hypnosis
Menopause-focused cognitive behavioral therapy can help reduce the distress and interference associated with hot flashes.
Cognitive behavioral therapy for insomnia is also effective for chronic sleep problems.
Clinical hypnosis is another evidence-supported nonhormonal option for vasomotor symptoms.
These approaches may be useful alone or alongside other treatments.
Bone Health and Osteoporosis Prevention
Postmenopausal bone loss increases the importance of bone health assessment.
Preventive strategies may include:
- Resistance and weight-bearing exercise
- Adequate calcium and vitamin D intake
- Fall prevention
- Avoiding tobacco
- Bone density testing when indicated
Women aged 65 and older are generally recommended to undergo osteoporosis screening. Younger postmenopausal women may need screening when additional risk factors are present.
When osteoporosis is diagnosed, medications specifically intended to reduce fracture risk may be recommended.
Menopausal hormone therapy has been shown to protect against bone density loss, but it is not the only option for protecting bone health. Hormone therapy is not FDA-approved for the treatment of osteoporosis, only the prevention of it. Once osteoporosis is present, treatment often requires a multidisciplinary approach including consultation with an Endocrinologist when available.
Cardiovascular and Metabolic Health
Cardiovascular risk increases with age, and menopause-related changes may contribute to shifts in cholesterol and body fat distribution. Lifestyle factors like diet, alcohol use, tobacco use, and exercise also play an important role.
Monitoring blood pressure, cholesterol, glucose, and other risk factors can help guide preventive care.
Hormone therapy has been shown to decrease cardiovascular risk when started before age 60 or within 10 years of menopause, but currently is not recommended or FDA-approved to be used specifically to prevent heart disease. The cardiovascular risks and benefits of hormone therapies vary depending on route of administration and timing of initiation, as well as personal medical and family history.
Mental Health Support
Depression, anxiety, or persistent mood symptoms may be part of the spectrum of menopause-related symptoms and can benefit from hormone therapy for some patients. However, they may require psychotherapy, mood-specific medication, sleep-focused treatment, or other interventions.
Although menopause symptoms can affect emotional well-being, established mental health conditions should receive appropriate care rather than being attributed solely to hormonal changes.
Frequently Asked Questions
Perimenopause is the transition leading up to menopause, when menstrual cycles and hormone levels become less predictable. Menopause is reached after 12 consecutive months without menstruation when no other cause explains the absence of periods. Postmenopause refers to the years following menopause.
Natural menopause most commonly occurs between ages 45 and 55, with an average age of approximately 51 in the United States. Menopause before age 45 is considered early, while symptoms suggesting ovarian insufficiency before age 40 require additional evaluation.
Symptoms vary considerably. Hot flashes, night sweats, and other menopause-related symptoms may last several years and can continue after the final menstrual period. Vaginal dryness and other genitourinary symptoms may persist or worsen without treatment. Some women experience few symptoms throughout the transition.
Menopause can contribute to changes in fat distribution, particularly increased abdominal fat. However, overall weight changes are also influenced by aging, physical activity, nutrition, sleep, and other metabolic factors. Weight gain is not inevitable, and hormone therapy is not prescribed specifically for weight loss.
Hormone therapy can be effective and appropriate for many women with bothersome symptoms both during perimenopause and after menopause. Safety depends on factors including age, time since menopause, medical history, treatment formulation, and individual risks. A personalized benefit-risk assessment is important because systemic hormone therapy is not suitable for everyone.
Most women aged 45 or older with typical symptoms and menstrual changes do not need routine hormone testing to confirm menopause. Hormone levels fluctuate during the transition, making single measurements difficult to interpret. Testing may be useful when symptoms occur unusually early, or the diagnosis is uncertain.
No. Any vaginal bleeding after menopause has been established should be medically evaluated, even if it is light or happens only once. Many causes are benign, but bleeding can sometimes indicate endometrial hyperplasia, cancer, or another condition requiring assessment.
References
- The Menopause Society — The 2022 Hormone Therapy Position Statement — Evidence-based guidance on menopausal hormone therapy benefits, risks, and treatment selection.
- The Menopause Society — The 2023 Nonhormone Therapy Position Statement — Evidence-based recommendations for nonhormonal treatment of vasomotor symptoms.
- National Institute on Aging — What Is Menopause? — Overview of natural menopause, reproductive aging, and common symptoms.
- NICE Guideline NG23 — Menopause: Identification and Management — Clinical guidance on diagnosis and treatment.
- World Health Organization — Menopause — Overview of menopause, causes, symptoms, and long-term health considerations.
- U.S. Food and Drug Administration — Menopause — Patient information about menopause treatments and hormone therapy.
- U.S. Preventive Services Task Force — Osteoporosis Screening — Recommendations for osteoporosis screening in postmenopausal women.





